📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: ImmuVen

1.1 - Company Overview

ImmuVen Logo

ImmuVen

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biotherapeutic discovery and drug development for infectious diseases, cancer, and autoimmune disorders.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to ImmuVen

InflaRx Logo

InflaRx

HQ: Germany Website
  • Description: Provider of therapeutics for acute and chronic inflammation targeting the C5a/C5aR pathway, including vilobelimab, a monoclonal antibody for chronic inflammatory diseases, oncology and critically ill COVID-19, authorized for emergency use by the FDA in hospitalized adults requiring invasive mechanical ventilation or ECMO, and INF904, an oral C5aR inhibitor in development for chronic spontaneous urticaria and hidradenitis suppurativa.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full InflaRx company profile →
Tubulis Logo

Tubulis

HQ: Germany Website
  • Description: Provider of chemotherapeutic medications for cancer and chronic disorders, developing disease-matched protein-drug conjugates (ADCs) using proprietary P5 conjugation chemistry and the Tubutecan linker-payload platform. Products include TUB-030 targeting 5T4 in solid tumors for long-lasting anti-tumor activity and TUB-040 targeting NaPi2b in ovarian and lung cancer for stable, potent delivery.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Tubulis company profile →
BriaCell Therapeutics Logo

BriaCell Therapeutics

HQ: United States Website
  • Description: Provider of immuno-oncology therapeutics developing targeted approaches for cancer management, including Bria-IMT™, a cell-based immunotherapy for advanced metastatic breast cancer that stimulates the immune system to target and kill cancer cells, and Bria-OTS™, a personalized off-the-shelf immunotherapy for advanced breast cancer engineered to match patients' HLA types.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BriaCell Therapeutics company profile →
Quest PharmaTech Logo

Quest PharmaTech

HQ: Canada Website
  • Description: Provider of antibody-based immunotherapeutic products for cancer and photodynamic therapy technology for oncology and dermatology, including Oregovomab, an antibody-based immunotherapy in clinical trials for ovarian cancer, and truncated MUC16-targeting Mab AR 9.6 as a theranostic agent.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Quest PharmaTech company profile →
Morphotek Logo

Morphotek

HQ: United States Website
  • Description: Provider of gene evolution-based monoclonal antibody products to treat cancer, inflammation, and infectious diseases. Offerings include RESPECT-H+L conjugation technology enabling dual payload delivery with in vivo ADC tracking, and an Eribulin ADC payload with cytotoxic effects on receptor-positive and neighboring receptor-negative tumor cells.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Morphotek company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for ImmuVen

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to ImmuVen

2.2 - Growth funds investing in similar companies to ImmuVen

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for ImmuVen

4.2 - Public trading comparable groups for ImmuVen

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to ImmuVen

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About ImmuVen

What does ImmuVen do?

ImmuVen is a provider of biotherapeutic discovery and drug development for infectious diseases, cancer, and autoimmune disorders.

Who are ImmuVen's competitors?

ImmuVen's competitors and similar companies include InflaRx, Tubulis, BriaCell Therapeutics, Quest PharmaTech, and Morphotek.

Where is ImmuVen headquartered?

ImmuVen is headquartered in United States.

How many employees does ImmuVen have?

ImmuVen has 1,000 employees 🔒.

When was ImmuVen founded?

ImmuVen was founded in 2010 🔒.

What sector and industry vertical is ImmuVen in?

ImmuVen is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for ImmuVen

Who are the top strategic acquirers in ImmuVen's sector and industry

Top strategic M&A buyers and acquirers in ImmuVen's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for ImmuVen?

Top strategic M&A buyers groups and sectors for ImmuVen include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in ImmuVen's sector and industry vertical

Which are the top PE firms investing in ImmuVen's sector and industry vertical?

Top PE firms investing in ImmuVen's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in ImmuVen's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in ImmuVen's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in ImmuVen's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to ImmuVen include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in ImmuVen's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for ImmuVen?

The key public trading comparables and valuation benchmarks for ImmuVen include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for ImmuVen for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for ImmuVen with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in ImmuVen's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for ImmuVen with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in ImmuVen's' sector and industry vertical?

Access recent funding rounds and capital raises in ImmuVen's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for ImmuVen